PDB59 EVALUATING THE COST-UTILITY OF ADDING SODIUM-GLUCOSE COTRANSPORTER INHIBITORS TO A BASAL-BOLUS INSULIN REGIMEN IN PATIENTS WITH TYPE 1 DIABETES IN THE UK: AN ANALYSIS USING THE PRIME DIABETES MODEL

Autor: Pollock, R., Valentine, W.J.
Zdroj: In Value in Health November 2019 22 Supplement 3:S583-S583
Databáze: ScienceDirect